Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease

Paediatric and Perinatal Epidemiology

Volumn 31, Issue 5, 2017, Pages 412-421

  Grandi, Sonia M ^a   Vallée Pouliot, Karine ^a   Reynier, Pauline ^b   Eberg, Maria ^b   Platt, Robert W ^a,c   Arel, Roxane ^a   Basso, Olga ^a,c   Filion, Kristian B ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

cardiovascular disease; hypertension; hypertensive disorders in pregnancy; marginal structural model; pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST; FEMALE; GESTATION PERIOD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MIGRAINE; OUTCOME ASSESSMENT; PARITY; POPULATION RESEARCH; PREGNANT WOMAN; PUERPERIUM; RISK ASSESSMENT; FOLLOW UP; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROPORTIONAL HAZARDS MODEL; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; UNITED KINGDOM; YOUNG ADULT;

EID: 85029682834     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/ppe.12388     Document Type: Article

References (31)

1. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstetrics and Gynecology 2009; 113:1299–1306.
2. Mannisto T, Mendola P, Vaarasmaki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013; 127:681–690.
3. Vest AR, Cho LS. Hypertension in pregnancy. Current Atherosclerosis Reports 2014; 16:395.
4. van Rijn BB, Nijdam ME, Bruinse HW, et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstetrics and Gynecology 2013; 121:1040–1048.
5. Valdiviezo C, Garovic VD, Ouyang P. Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. Clinical Cardiology 2012; 35:160–165.
6. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123:2856–2869.
7. Skjaerven R, Wilcox AJ, Klungsoyr K, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012; 345:e7677.
8. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323:1213–1217.
9. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstetrics and Gynecology 2009; 114:961–970.
10. The Clinical Practice Research Datalink. http://www.cprd.com/intro.asp. [last accessed 1 March 2014], 2014.
11. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). International Journal of Epidemiology 2015; 44:827–836.
12. Chisholm J. The read clinical classification. BMJ 1990; 300:1092.
13. Magee LA, Helewa M, Moutquin JM, von Dadelszen P Hypertension Guideline C Strategic Training Initiative in Research in the Reproductive Health Sciences S. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Journal of Obstetrics and Gynaecology Canada 2008;30:S1–S48.
14. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy: National Institute for Health and Clinical Excellence; January. Report No.: NICE Clinical Guideline 107, 2011.
15. Eberg M, Platt RW, Filion KB. The estimation of gestational age at birth in database studies. Epidemiology 2017; Jul 7. doi: 10.1097/EDE.0000000000000713 [Epub ahead of print].
16. Jukic AM, Baird DD, Weinberg CR, McConnaughey DR, Wilcox AJ. Length of human pregnancy and contributors to its natural variation. Human Reproduction 2013; 28:2848–2855.
17. Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernandez-Diaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiology and Drug Safety 2013; 22:16–24.
18. Schafer JL. Multiple imputation: a primer. Statistical Methods in Medical Research 1999; 8:3–15.
19. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561–570.
20. Mammaro A, Carrara S, Cavaliere A, et al. Hypertensive disorders of pregnancy. Journal of Prenatal Medicine 2009; 3:1–5.
21. Saftlas AF, Levine RJ, Klebanoff MA, et al. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. American Journal of Epidemiology 2003; 157:1108–1114.
22. The American College of Obstetrics and Gynecologists. Key Elements for the Management of Hypertensive Crisis in Pregnancy (In-Patient). Clinical Practice Guidelines. http://www.acog.org/~/media/Districts/District%20II/PDFs/Optimizing_Protocols_In_OB_HTN_Series_3-%20Version%201.pdf?dmc=1 [last accessed 1 February 2016], 2013.
23. Garovic VD, Bailey KR, Boerwinkle E, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. Journal of Hypertension 2010; 28:826–833.
24. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326:845.
25. Smith GN, Pudwell J, Walker M, Wen SW. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. Journal of Obstetrics and Gynaecology Canada 2012; 34:830–835.
26. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010; 56:166–171.
27. Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Pre-eclampsia and future cardiovascular risk among women: a review. Journal of the American College of Cardiology 2014; 63:1815–1822.
28. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. American Journal of Epidemiology 2008; 168:656–664.
29. Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. Journal of Hypertension 2014; 32:849–856.
30. Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. Maternal cardiovascular changes from pre-pregnancy to very early pregnancy. Journal of Hypertension 2012; 30:2168–2172.
31. Babinszki A, Kerenyi T, Torok O, Grazi V, Lapinski RH, Berkowitz RL. Perinatal outcome in grand and great-grand multiparity: effects of parity on obstetric risk factors. American Journal of Obstetrics and Gynecology 1999; 181:669–674.